submit news    HOME | FEEDBACK  


« NAVIGATION »
NEWS

- Bio/Medicine

- Chemicals

- Defense

- Drug Delivery

- Education

- Electronics

- Energy

- Events

- Grants

- Industry

- Investment

- Litigation

- Materials

- MEMS

- Nanofabrication

- Nanoparticles

- Nanotubes

- Optics

- Partnership

- Patent

- Products

- Quantum dots

- Research

- Smart Dust

- Software
COMPANIES
EVENTS

- Browse by Month

- Current Shows

- Previous Shows

- Submit Events
FEEDBACK
ADVERTISE
LINK TO US

« PARTNERS »
Become A Nanotechwire Partner

FEI Company

Veeco Instruments

Nano Science and Technology Institute

National Nanotechnology Initiative

Nanotechnology at Zyvex

Want to see your Company or Organization listed above? Become A Nanotechwire Partner Today - click here
« NEWSLETTER »



« SEARCH »







10/25/2005 6:50:08 PM
Biophan CEO to Highlight Breakthrough Nanotechnology-Based Biomedical Applications at Foresight Institute Conference

Biophan Technologies, Inc., a developer of next-generation medical technology, has announced that representatives of the Company will present the Company's breakthrough nanotechnology-based healthcare applications and its business strategies to monetize its innovations at the 13th Foresight Conference on Advanced Nanotechnology, scheduled to take place October 22 - 27, in San Francisco, CA.

An update on the Company's breakthrough nanotechnology innovations will be presented, including solutions to improve safety and effectiveness of Magnetic Resonance Imaging (MRI) in healthcare, unique thermoelectric battery technology designed to power implantable medical devices, advanced contrast agents for medical imaging, and next-generation applications for the drug delivery and drug-elution marketplace. This presentation is scheduled for October 25, at 12:30 p.m. Pacific.

In addition, the Company's business strategy will be presented in the conference's "Public Equity Roundtable" presentation, scheduled for 5:45 p.m. on October 25.

"The Foresight conference will provide valuable investor and industry exposure for our array of innovative nanotechnology applications," said Mr. Weiner. "Our business plan is designed to leverage these next-generation solutions to enable a range of products for various healthcare market segments, such as advanced drug-delivery systems, an implantable biothermal power supply, enhanced MRI imaging, and others."

The Company recently launched an initiative to expand its presence in cardiovascular diagnostic and therapeutic devices, one of the fastest-growing segments of the biomedical industry, with the potential to reach nearly $28 billion before the end of this decade.

Other Headlines from Biophan ...
 - Biophan Licensor Issued Broad Patent on Nanomagnetic Coatings
 - Biophan Files Drug Delivery Patent for Use of NaturalNano's Halloysite Nanotubes
 - Biophan Files Broad Patent on Use of Halloysite Nanotubes for New Drug Delivery Applications
 - Biophan Joins as Senior Member of Prestigious Engineering Research Center at USC Supported by National Science Foundation
 - Biophan to Receive Nano 50 ``Best of the Best'' Award for Innovation in Nanotechnology at NASA Tech Briefs Conference

More Events Headlines ...
 - Free Keithley Web-Based Seminar Addresses High Brightness LED Test Techniques
 - Leading UK Nano Organisations lend support for NANO Live UK 2011
 - Asylum Research Announces UK User Meeting and Forum June 21, 2011 in Edinburgh
 - CEA-Leti to Present 2 Invited Papers at May 23-26 Conference on Frontiers of Characterization and Metrology for Nanoelectronics
 - UAlbany NanoCollege to host prestigious International Nanotechnology Conference on Communication and Cooperation


« Back To List »

« GET LISTED »
- submit company
- submit news
- submit events
- advertise here

« EVENTS »
- More Events


Copyright 2014 Nanotechwire.com | Privacy Policy |